JAKARTA – When the Covid-19 pandemic struck Indonesia early last year, it didn’t take long for businessman Haryoseno to latch on to a 40-year-old parasitic drug known as Ivermectin as a potentially cheap and effective way to treat the coronavirus. Using raw materials imported from India, his Jakarta-based Harsen Laboratories pharmaceutical firm produced a large cache […]
Thank you for registering!
An account was already registered with this email. Please check your inbox for an authentication link.